<
>
Ixazomib Citrate (1201902-80-8)
Product Summary
Ixazomib Citrate (1201902-80-8) Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and ...
Product Custom Attributes
CAS:
1201902-80-8
Specification:
CP, EP, In-house, As Required
M.F.:
C20H23BCl2N2O9
M.W.:
517.12
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Ixazomib Citrate 1201902-80-8
,Ixazomib API 1201902-80-8
,Ixazomib proteasome inhibitor
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS: 1201902-80-8; Ixazomib manufacturer; Ixazomib API; Ixazomib proteasome inhibitor; Anti-Tumor
Payment Terms:
L/C, T/T
Product Description
Ixazomib Citrate (1201902-80-8)
Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and anticancer activity.
| Product Name: | Ixazomib Citrate |
| CAS No.: | 1201902-80-8 |
| Assay: | 98% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C20H23BCl2N2O9 |
| Molecular Weight: | 517.12 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
